Wire · opportunities
Cepheid Receives FDA Clearance for Xpert® Hemorrhagic Fever Panel Test
◆ Sectors
Diagnostics
◆ Geography
United States
◆ Source
◆ Verified
Fusion42 · 4 November 2026 · Fusion42 review
Cepheid has received FDA clearance for its Xpert Hemorrhagic Fever Panel, a multiplex PCR test that detects Ebola, Marburg, Lassa, and Crimean-Congo hemorrhagic fever viruses within approximately 61 minutes.
This Wire brief sits within Fusion42's coverage of Diagnostics.
◆ ◆ The Wire takeaway
Receiving FDA clearance accelerates your ability to offer fast hemorrhagic fever diagnostics in the US market. This opens a critical pathway for clinical rollout and positions you in urgent infectious disease testing.
◆ Coverage
1 source · 4 Nov 2026
◆ Related on Wire
◆ Topics
DiagnosticsFDA-clearancediagnosticsmultiplex-PCRhemorrhagic-feverCepheid